When.com Web Search

  1. Ad

    related to: neuromod tinnitus fda approval

Search results

  1. Results From The WOW.Com Content Network
  2. Tinnitus - Wikipedia

    en.wikipedia.org/wiki/Tinnitus

    In March 2023, the US Food and Drug Administration (FDA) approved Neuromod's Lenire device as a treatment option for tinnitus. [ 130 ] [ 131 ] [ 132 ] In June 2024, the US Department of Veterans Affairs (VA) announced it would begin offering the treatment to veterans with tinnitus, making it the first bimodal neuromodulation device to be ...

  3. AOL Mail

    mail.aol.com

    Get AOL Mail for FREE! Manage your email like never before with travel, photo & document views. Personalize your inbox with themes & tabs. You've Got Mail!

  4. Ebselen - Wikipedia

    en.wikipedia.org/wiki/Ebselen

    Ebselen (also called PZ 51, DR3305, and SPI-1005), is a synthetic organoselenium drug molecule with anti-inflammatory, anti-oxidant and cytoprotective activity.It acts as a mimic of glutathione peroxidase and can also react with peroxynitrite. [1]

  5. Neuromodulation (medicine) - Wikipedia

    en.wikipedia.org/wiki/Neuromodulation_(medicine)

    Deep brain stimulation was approved by the U.S. Food and Drug Administration in 1997 for essential tremor, in 2002 for Parkinson's disease, and received a humanitarian device exemption from the FDA in 2003 for motor symptoms of dystonia. [23] It was approved in 2010 in Europe for the treatment of certain types of severe epilepsy. [24]

  6. Tinnitus retraining therapy - Wikipedia

    en.wikipedia.org/wiki/Tinnitus_retraining_therapy

    pharmacological – No drug has been approved by the U.S. Food and Drug Administration (FDA) for treating tinnitus. However, various pharmacological treatments, including antidepressants, anxiolytics, vasodilators and vasoactive substances, and intravenous lidocaine have been prescribed for tinnitus [ 21 ]

  7. Betahistine - Wikipedia

    en.wikipedia.org/wiki/Betahistine

    Betahistine was once believed to have some positive effects in the treatment of Ménière's disease and vertigo, [3] but more recent evidence casts doubt on its efficacy. [4] [5] Studies of the use of betahistine have shown a reduction in symptoms of vertigo and, to a lesser extent, tinnitus, but conclusive evidence is lacking at present.

  8. US FDA approves Ionis Pharma's genetic disorder drug - AOL

    www.aol.com/news/us-fda-approves-ionis-pharmas...

    (Reuters) -The U.S. Food and Drug Administration has approved Ionis Pharmaceuticals' drug to treat a rare genetic disorder, making it the company's first wholly-owned drug, the health regulator's ...

  9. Robert F. Kennedy Jr.'s personal attorney previously lobbied the Food and Drug Administration to revoke its approval of the polio vaccine, highlighting an influential Kennedy ally who, sources ...